GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Egetis Therapeutics AB (OSTO:EGTX) » Definitions » Total Debt per Share

Egetis Therapeutics AB (OSTO:EGTX) Total Debt per Share : kr0.32 (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Egetis Therapeutics AB Total Debt per Share?

kr0.32 (As of Dec. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Egetis Therapeutics AB's Total Debt Per Share for the quarter that ended in Dec. 2024 was kr0.32.

Egetis Therapeutics AB Total Debt per Share Historical Data

The historical data trend for Egetis Therapeutics AB's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egetis Therapeutics AB Total Debt per Share Chart

Egetis Therapeutics AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.02 0.01 0.39 0.32

Egetis Therapeutics AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.40 0.37 0.38 0.32

Egetis Therapeutics AB Total Debt per Share Calculation

Egetis Therapeutics AB's Total Debt Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(84.10+30.10)/359.24
=0.32

Egetis Therapeutics AB's Total Debt Per Share for the quarter that ended in Dec. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(84.10+30.10)/359.24
=0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Egetis Therapeutics AB Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Egetis Therapeutics AB's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Egetis Therapeutics AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Egetis Therapeutics AB (OSTO:EGTX) » Definitions » Total Debt per Share
Comparable Companies
OSTO:GENO OSTO:DMYD B OSTO:VICO OSTO:BINV OSTO:HNSA OSTO:XSPRAY OSTO:SYNACT OSTO:SANION OSTO:IRLAB A OSTO:ABLI VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
0ABW:UK P0F:Germany
Address
Grev Turegatan 11 C, Stockholm, SWE, 114 46
Website
https://www.egetis.com
Egetis Therapeutics AB is an integrated pharmaceutical drug development company, focusing on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment.

Egetis Therapeutics AB Headlines

No Headlines